Alzheimer Europe 2020 Conference, Lessons from COVID-19 for Alzheimer's health system readiness
Coronavirus: Description video
Watch the video “Alzheimer Europe 2020 Conference, Lessons from COVID-19 for Alzheimer's health system readiness” and like it!
Special symposium SS2. Lessons from COVID-19 for AD health system readiness
Chairperson: Lydia Lanman (Switzerland)
With the participation of:
• Soeren Mattke (USA)
• Iva Holmerova (Czech Republic)
• Chris Lynch (United Kingdom)
• Maria Soto (France)
• Martin Traber (Switzerland)
Alzheimer’s disease (AD) is a progressive neurodegenerative disease which places a tremendous burden on individuals, caregivers, families and society. While there are currently no approved treatments that can change the course of the disease, there is need for health systems to prepare, ensuring new medical advances can be available to people living with AD when they do become available. The response to the COVID-19 pandemic offers important lessons for health system readiness for Alzheimer's disease (AD) in Europe. Across countries, the COVID-19 pandemic has clearly shown that without the right measures in place, even highly-resourced healthcare systems can become rapidly overwhelmed by an unpredictable healthcare crisis that affects a large population. The COVID-19 pandemic illustrates the importance of analysing robust data correctly and responding quickly to changing scenarios by using healthcare resources effectively and efficiently. Specifically, the AD community itself has been directly affected by the prevailing COVID-19 situation as individuals are often considered at higher risk of mortality and morbidity. This highlights the fragility of the current approaches to diagnosis, treatment and care for people living with AD. The number of people with AD is growing, and as illustrated by the COVID-19 pandemic, action needs to be taken now to prepare health systems for the future rising demand from patients and their families as new diagnostic and treatment innovations emerge. An expert panel will share their perspectives on and experiences of the lessons to be learned from COVID-19 for AD health system readiness. To better understand the challenges and opportunities, the panel will explore a range of topics, from healthcare access and service coverage, capacity constraints, the respective roles of primary and specialist care, and how to ensure medical innovation can support a patient-centred care model in AD.
This special symposium is organised by Roche.
Liked the “Alzheimer Europe 2020 Conference, Lessons from COVID-19 for Alzheimer's health system readiness” video?
Share it with your friends!